Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7318 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7318-7318

Author(s):

U. Abacioglu ◽

P. F. Yumuk ◽

H. Caglar ◽

M. Sengoz ◽

N. S. Turhal

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Low Dose ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer

10.1186/1471-2407-5-71 ◽

2005 ◽

Vol 5 (1) ◽

Author(s):

Ufuk Abacioglu ◽

Perran F Yumuk ◽

Hale Caglar ◽

Meric Sengoz ◽

Nazim S Turhal

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Low Dose ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Results of concurrent chemoradiotherapy (CRT) with low dose weekly gemcitabine (G) in stage III non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7318 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7318-7318

Author(s):

U. Abacioglu ◽

P. F. Yumuk ◽

H. Caglar ◽

M. Sengoz ◽

N. S. Turhal

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Low Dose ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients with Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.05.009 ◽

2021 ◽

Author(s):

Mark A. Socinski ◽

Mustafa Özgüroğlu ◽

Augusto Villegas ◽

Davey Daniel ◽

David Vicente ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

500 Concurrent low-dose daily carboplatin (CBDCA) and hyperfractionated radiotherapy (HFX-RT) in stage III non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(97)89880-7 ◽

1997 ◽

Vol 18 ◽

pp. 128

Author(s):

Y. Yoshida ◽

K. Kashiwado ◽

K. Suenaga

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Low Dose ◽

Stage Iii ◽

Small Cell Lung ◽

Hyperfractionated Radiotherapy

Download Full-text

Preoperative Concurrent Chemoradiotherapy of S-1/Cisplatin for Stage III Non-Small Cell Lung Cancer

The Annals of Thoracic Surgery ◽

10.1016/j.athoracsur.2013.06.036 ◽

2013 ◽

Vol 96 (5) ◽

pp. 1783-1789 ◽

Author(s):

Masafumi Yamaguchi ◽

Gouji Toyokawa ◽

Taro Ohba ◽

Tomonari Sasaki ◽

Takuro Kometani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

Durvalumab after concurrent chemoradiotherapy in a patient with chemotherapy-resistant unresectable stage III non-small cell lung cancer: a case report

Annals of Palliative Medicine ◽

10.21037/apm-20-1118 ◽

2020 ◽

Vol 9 (4) ◽

pp. 2375-2380 ◽

Author(s):

Tao Zhang ◽

Yuqi Wu ◽

Shan Zheng ◽

Guowei Cheng ◽

Xiangling He ◽

...

Keyword(s):

Lung Cancer ◽

Case Report ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung ◽

Unresectable Stage

Download Full-text

Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)—a German radiation oncology survey

Translational Lung Cancer Research ◽

10.21037/tlcr.2020.03.25 ◽

2020 ◽

Vol 9 (2) ◽

pp. 288-293

Author(s):

Lukas Käsmann ◽

Chukwuka Eze ◽

Julian Taugner ◽

Olarn Roengvoraphoj ◽

Claus Belka ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Radiation Oncology ◽

Maintenance Treatment ◽

Concurrent Chemoradiotherapy ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

1255TiP CheckMate 73L: A phase III study comparing nivolumab (NIVO) plus concurrent chemoradiotherapy (CCRT) followed by NIVO ± ipilimumab (IPI) versus CCRT followed by durvalumab (DURV) for previously untreated, locally advanced (LA) stage III non-small cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.128 ◽

2020 ◽

Vol 31 ◽

pp. S810

Author(s):

D. De Ruysscher ◽

S.S. Ramalingam ◽

J. Urbanic ◽

D.E. Gerber ◽

D.S.W. Tan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Phase Iii ◽

Stage Iii ◽

Small Cell Lung ◽

Phase Iii Study

Download Full-text

427PD Prognostic significance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy

Annals of Oncology ◽

10.1093/annonc/mdv532.11 ◽

2015 ◽

Vol 26 ◽

pp. ix125

Author(s):

N. Matsuo ◽

T. Tokito ◽

K. Azuma ◽

H. Ishii ◽

K. Yamada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Prognostic Significance ◽

Stage Iii ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2014.11.039 ◽

2015 ◽

Vol 114 (2) ◽

pp. 161-166 ◽

Author(s):

Yong Bao ◽

Fang Peng ◽

Qi-Chao Zhou ◽

Zhong-Hua Yu ◽

Jian-Cheng Li ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Concurrent Chemoradiotherapy ◽

Phase Ii Trial ◽

Stage Iii ◽

Small Cell Lung ◽

Recombinant Human Endostatin

Download Full-text